ArticleFrontiers in global women's health2025
Associations of hemoglobin trajectories and time in target hemoglobin range with adverse pregnancy outcomes: a real-world pregnancy records-based study.
Article in Frontiers in global women's health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: This study aimed to evaluate associations of hemoglobin trajectories during pregnancy and time spent within clinically recommended hemoglobin ranges (Hb-TITR) with adverse pregnancy outcomes. Methods: A retrospective cohort study was conducted using pregnancy records from Shanghai First Maternity and Infant Hospital (from January 2022 to December 2024), involving 7,653 pregnant women with complete serial hemoglobin measurements. Hemoglobin trajectories were categorized as stable, descending, or ascending. Hb-TITR was calculated based on clinically recommended hemoglobin ranges throughout pregnancy. Logistic regression analyses were performed to determine associations with adverse outcomes, adjusting for maternal age, pre-pregnancy BMI, and gestational age. Results: Among participants, 85.2% exhibited stable hemoglobin trajectories, 10.4% descending, and 4.4% ascending. Descending trajectory was significantly associated with increased risk of composite adverse outcomes [adjusted odds ratio (OR) 3.92; 95% CI, 3.30-4.66] compared with the stable group. Conversely, ascending trajectory showed no significant risk elevation (OR 1.13; 95% CI, 0.83-1.51). Reduced Hb-TITR (<80%) significantly increased the odds of adverse outcomes (OR 1.35; 95% CI, 1.10-1.65), whereas longer Hb-TITR was protective. Descending trajectories notably increased risks of PROM, cesarean section, postpartum hemorrhage, macrosomia, SGA, and LGA infants. Conclusion: Descending hemoglobin trajectories and reduced time spent within recommended hemoglobin ranges during pregnancy were significantly associated with increased risks of adverse maternal and neonatal outcomes, highlighting the importance of monitoring hemoglobin dynamics throughout pregnancy.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.